MA38169B2 - Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux - Google Patents
Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevauxInfo
- Publication number
- MA38169B2 MA38169B2 MA38169A MA38169A MA38169B2 MA 38169 B2 MA38169 B2 MA 38169B2 MA 38169 A MA38169 A MA 38169A MA 38169 A MA38169 A MA 38169A MA 38169 B2 MA38169 B2 MA 38169B2
- Authority
- MA
- Morocco
- Prior art keywords
- disease
- ciclesonide
- horses
- treatment
- respiratory tract
- Prior art date
Links
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 title abstract 2
- 208000018569 Respiratory Tract disease Diseases 0.000 title abstract 2
- 229960003728 ciclesonide Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- 208000000884 Airway Obstruction Diseases 0.000 abstract 1
- 208000019693 Lung disease Diseases 0.000 abstract 1
- 208000011623 Obstructive Lung disease Diseases 0.000 abstract 1
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 229940037128 systemic glucocorticoids Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12199302 | 2012-12-21 | ||
| PCT/EP2013/077265 WO2014096115A1 (en) | 2012-12-21 | 2013-12-18 | Ciclesonide for the treatment of airway disease in horses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA38169A1 MA38169A1 (fr) | 2017-01-31 |
| MA38169B2 true MA38169B2 (fr) | 2021-08-31 |
Family
ID=47552829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA38169A MA38169B2 (fr) | 2012-12-21 | 2013-12-18 | Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux |
Country Status (24)
| Country | Link |
|---|---|
| US (4) | US20140179651A1 (enExample) |
| EP (1) | EP2934479B1 (enExample) |
| AR (1) | AR094241A1 (enExample) |
| AU (2) | AU2013360691B2 (enExample) |
| BR (2) | BR122016029247A2 (enExample) |
| CA (1) | CA2888428C (enExample) |
| CY (2) | CY1121115T1 (enExample) |
| DK (1) | DK2934479T3 (enExample) |
| ES (1) | ES2693779T3 (enExample) |
| FR (1) | FR20C1026I1 (enExample) |
| HR (1) | HRP20181980T1 (enExample) |
| HU (1) | HUS2000020I1 (enExample) |
| IN (1) | IN2015DN02894A (enExample) |
| LT (2) | LT2934479T (enExample) |
| MA (1) | MA38169B2 (enExample) |
| MX (1) | MX368306B (enExample) |
| NO (1) | NO2020014I1 (enExample) |
| NZ (1) | NZ706573A (enExample) |
| PL (1) | PL2934479T3 (enExample) |
| PT (1) | PT2934479T (enExample) |
| RS (1) | RS57740B1 (enExample) |
| SI (1) | SI2934479T1 (enExample) |
| WO (1) | WO2014096115A1 (enExample) |
| ZA (1) | ZA201502288B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2014001557A (es) | 2011-08-12 | 2014-03-31 | Boehringer Ingelheim Vetmed | Inhibidores de corrientes funny (if) para utilizar en un metodo de tratamiento y prevencion de la insuficiencia cardiaca en felinos. |
| MX364652B (es) | 2012-12-21 | 2019-05-03 | Boehringer Ingelheim Vetmedica Gmbh | Formulacion farmaceutica que comprende ciclesonida. |
| IN2015DN02894A (enExample) | 2012-12-21 | 2015-09-11 | Boehringer Ingelheim Vetmed | |
| KR102618119B1 (ko) | 2014-06-18 | 2023-12-27 | 베링거잉겔하임베트메디카게엠베하 | 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물 |
| WO2018070819A1 (ko) * | 2016-10-14 | 2018-04-19 | 제주대학교 산학협력단 | 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물 |
| US20230033224A1 (en) * | 2020-01-10 | 2023-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for ameliorating quality of life (qol) in equines |
| CN115989032A (zh) | 2020-07-31 | 2023-04-18 | 化学研究有限公司 | 用于吸入施用的组合疗法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5954049A (en) | 1991-10-15 | 1999-09-21 | Trudell Medical Limited | Equine mask with MDI adapter |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
| US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
| US6706726B2 (en) | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
| DE10050994A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
| DE10062712A1 (de) | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| US6904908B2 (en) | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
| US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
| DE10237739A1 (de) | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
| AU2003272450A1 (en) | 2002-09-13 | 2004-04-30 | C. Steven Smith | Novel composition and method for treatment of upper respiratory conditions |
| JP2006528228A (ja) * | 2003-05-22 | 2006-12-14 | アルタナ ファルマ アクチエンゲゼルシャフト | サルメテロール及びシクレソニドの組合せ物 |
| US20050020692A1 (en) | 2003-07-24 | 2005-01-27 | Ciofalo Vincent B. | Treatment of heaves |
| DK1670482T4 (da) | 2003-09-16 | 2022-08-22 | Covis Pharma B V | Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme |
| PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
| US20070134165A1 (en) | 2004-04-20 | 2007-06-14 | Altana Pharma Ag | Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient |
| WO2006003078A1 (en) | 2004-06-29 | 2006-01-12 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising steroids and an anticholinergic |
| DE102004056579A1 (de) | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid |
| UY30542A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
| UY30543A1 (es) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| ES2593428T3 (es) | 2009-06-25 | 2016-12-09 | Boehringer Ingelheim Vetmedica Gmbh | Inhalador |
| US7829748B1 (en) * | 2009-09-21 | 2010-11-09 | Honeywell International Inc. | Process for the manufacture of 1,3,3,3-tetrafluoropropene |
| US20150202297A1 (en) | 2012-07-05 | 2015-07-23 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose and a ternary component |
| EA201590019A1 (ru) | 2012-07-05 | 2015-09-30 | Арвен Айлак Санайи Ве Тиджарет А.С. | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы |
| US9539408B2 (en) | 2012-10-31 | 2017-01-10 | Trudell Medical International | Nebulizer apparatus |
| MX364652B (es) | 2012-12-21 | 2019-05-03 | Boehringer Ingelheim Vetmedica Gmbh | Formulacion farmaceutica que comprende ciclesonida. |
| IN2015DN02894A (enExample) | 2012-12-21 | 2015-09-11 | Boehringer Ingelheim Vetmed | |
| PL3035885T3 (pl) | 2013-08-20 | 2020-06-29 | Boehringer Ingelheim Vetmedica Gmbh | Inhalator |
| HRP20201987T1 (hr) | 2013-08-20 | 2021-02-05 | Boehringer Ingelheim Vetmedica Gmbh | Inhalator |
| KR102618119B1 (ko) | 2014-06-18 | 2023-12-27 | 베링거잉겔하임베트메디카게엠베하 | 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물 |
-
2013
- 2013-12-18 IN IN2894DEN2015 patent/IN2015DN02894A/en unknown
- 2013-12-18 PL PL13811924T patent/PL2934479T3/pl unknown
- 2013-12-18 AU AU2013360691A patent/AU2013360691B2/en active Active
- 2013-12-18 US US14/132,580 patent/US20140179651A1/en not_active Abandoned
- 2013-12-18 EP EP13811924.3A patent/EP2934479B1/en active Active
- 2013-12-18 MA MA38169A patent/MA38169B2/fr unknown
- 2013-12-18 PT PT13811924T patent/PT2934479T/pt unknown
- 2013-12-18 RS RS20181190A patent/RS57740B1/sr unknown
- 2013-12-18 CA CA2888428A patent/CA2888428C/en active Active
- 2013-12-18 HR HRP20181980TT patent/HRP20181980T1/hr unknown
- 2013-12-18 LT LTEP13811924.3T patent/LT2934479T/lt unknown
- 2013-12-18 NZ NZ70657313A patent/NZ706573A/en unknown
- 2013-12-18 US US14/654,009 patent/US9918995B2/en active Active
- 2013-12-18 WO PCT/EP2013/077265 patent/WO2014096115A1/en not_active Ceased
- 2013-12-18 BR BR122016029247-9A patent/BR122016029247A2/pt not_active Application Discontinuation
- 2013-12-18 MX MX2015007947A patent/MX368306B/es active IP Right Grant
- 2013-12-18 DK DK13811924.3T patent/DK2934479T3/en active
- 2013-12-18 SI SI201331266T patent/SI2934479T1/sl unknown
- 2013-12-18 BR BR112015010842-3A patent/BR112015010842B1/pt active IP Right Grant
- 2013-12-18 ES ES13811924.3T patent/ES2693779T3/es active Active
- 2013-12-20 AR ARP130104978A patent/AR094241A1/es not_active Application Discontinuation
-
2015
- 2015-04-07 ZA ZA2015/02288A patent/ZA201502288B/en unknown
-
2016
- 2016-10-13 US US15/292,765 patent/US10258634B2/en active Active
-
2018
- 2018-02-06 US US15/889,307 patent/US10441597B2/en active Active
- 2018-03-07 AU AU2018201642A patent/AU2018201642B2/en active Active
- 2018-11-09 CY CY181101189T patent/CY1121115T1/el unknown
-
2020
- 2020-06-12 NO NO2020014C patent/NO2020014I1/no unknown
- 2020-06-18 LT LTPA2020511C patent/LTPA2020511I1/lt unknown
- 2020-06-26 FR FR20C1026C patent/FR20C1026I1/fr active Active
- 2020-06-29 HU HUS2000020C patent/HUS2000020I1/hu unknown
- 2020-06-29 CY CY2020015C patent/CY2020015I2/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA38169A1 (fr) | Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux | |
| EA031157B9 (ru) | Вводимая перорально кортикостероидная композиция | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| EP2582676A4 (en) | POSITIVE ALLOSTERIC TETRAHYDROCHINOLINE AMID M1 RECEPTOR MODULATORS | |
| EA201290519A1 (ru) | Положительные аллостерические модуляторы рецептора хинолин амида m1 | |
| MX2022008181A (es) | Composiciones farmaceuticas que comprenden un compuesto de dextrometorfano y quinidina para el tratamiento de agitacion en demencia. | |
| EP2666471A4 (en) | PHARMACEUTICAL COMPOSITION FOR MILK AND LIVER AND MANUFACTURING METHOD THEREFOR | |
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| EA201001781A1 (ru) | Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов | |
| EA200802020A1 (ru) | Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1 | |
| PH12016500746B1 (en) | A novel formulation of meloxicam | |
| MX2016016720A (es) | Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. | |
| RU2016132762A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| TR201000733A2 (tr) | Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler. | |
| NZ596218A (en) | Bssl antagonists for treatment of inflammatory diseases | |
| WO2009134668A3 (en) | 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators | |
| SG10201809506TA (en) | Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | |
| EP2431049A4 (en) | Pharmaceutical preparation for administration to the respiratory system Prevention of inflammatory respiratory diseases and methods of treatment or PREVENTION OF SUCH DISEASES | |
| PH12015502560B1 (en) | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease | |
| PH12016501119A1 (en) | Zirconium silicate for treating hyperkalemia without co-administering lithium | |
| FR2927256B1 (fr) | Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation | |
| FR2960780B1 (fr) | Medicament pour le traitement de la maladie de parkinson | |
| Wollin et al. | PI3kinase Gamma Kinase Dead Knock-In Mice Are Protected Against Cigarette Smoke-Induced Pulmonary Inflammation | |
| ATE522537T1 (de) | (e)-n-ä3-ä1-(8-fluor-11h-10-oxa-1-aza-dibenzo-ä , dü-cyclohepten-5-yliden)-propylü-phenylü- methylsulfon-amid als glucocorticoid- rezeptormodulator zur behandlung rheumatoider arthritis |